Mitochondrial-derived peptides: New markers for cardiometabolic dysfunction - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Archives of cardiovascular diseases Année : 2021

Mitochondrial-derived peptides: New markers for cardiometabolic dysfunction


Great attention is being paid to the evaluation of new markers in blood circulation for the estimation of tissue metabolism disturbance. This endogenous disturbance may contribute to the onset and progression of cardiometabolic disease. In addition to their role in energy production and metabolism, mitochondria play a main function in cellular mechanisms, including apoptosis, oxidative stress and calcium homeostasis. Mitochondria produce mitochondrial-derived peptides that mediate the transcriptional stress response by translocating into the nucleus and interacting with deoxyribonucleic acid. This class of peptides Abbreviations: ATP, adenosine triphosphate; CMD, coronary microvascular dysfunction; CNTFR, ciliary neuronotrophic factor receptor; DNA, deoxyribonucleic acid; ERK1/2, extracellular signal-regulated kinase 1/2; FPRL1, formyl peptide receptor-like 1; IGF-1, insulin-like growth factor-1; MDPs, mitochondrial-derived peptides; MOTS-c, mitochondrial open reading frame of the 12S ribosomal ribonucleic acid type c; mtDNA, mitochondrial deoxyribonucleic acid; ROS, reactive oxygen species; SHLP, small humanin-like peptide; STAT3, signal transducer and activator of transcription 3.
Fichier non déposé

Dates et versions

hal-03822684 , version 1 (24-10-2022)



Luc Rochette, Eve Rigal, Geoffrey Dogon, Gabriel Malka, Marianne Zeller, et al.. Mitochondrial-derived peptides: New markers for cardiometabolic dysfunction. Archives of cardiovascular diseases, 2021, 115, pp.48 - 56. ⟨10.1016/j.acvd.2021.10.013⟩. ⟨hal-03822684⟩
6 Consultations
1 Téléchargements



Gmail Facebook Twitter LinkedIn More